StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
BrainsWay Ltd.
Tel Aviv Stock Exchange:BWAY.TA
Sector
Location
Market Cap
USD 253.28 M
Share Price
USD 6.03
Avg Daily Volume
57,760
Change (1 day)
-0.85%
Change (1 year)
89.43%
Change (YTD)
31.67%
BrainsWay Ltd. Shareholders' Equity for the year ending December 31, 2024: USD 62.31 M
BrainsWay Ltd. Shareholders' Equity is USD 62.31 M for the year ending December 31, 2024, a 49.86% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
BrainsWay Ltd. Shareholders' Equity for the year ending December 31, 2023 was USD 41.58 M, a -8.41% change year over year.
-
BrainsWay Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 45.40 M, a -20.81% change year over year.
-
BrainsWay Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 57.32 M, a 191.96% change year over year.
-
BrainsWay Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 19.63 M, a -18.93% change year over year.
Competitors
Neurocrine Biosciences, Inc.
USD 133.66
NBIX
+0.91
0.69%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Siemens Healthineers AG
USD 54.74
SHL.DE
+1.05
1.95%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Neurocrine Biosciences, Inc.
USD 133.66
NBIX
+0.91
0.69%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Siemens Healthineers AG
USD 54.74
SHL.DE
+1.05
1.95%